Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Huysmans, D. A.K.C.    Kloppenborg, P. W.C.    Related Articles in PubMed    PubMed Citation    PubMed

ARTICLE

Large, Compressive Goiters Treated with Radioiodine

Dyde A.K.C. Huysmans; Ad R.M.M. Hermus; Frans H.M. Corstens; Jelle O. Barentsz; and Peter W.C. Kloppenborg

15 November 1994 | Volume 121 Issue 10 | Pages 757-762

Objective: To evaluate the effectiveness of radioiodine therapy as an alternative for surgery in elderly patients with a large, compressive goiter using objective methods for measuring thyroid volume and tracheal compression.

Design: Prospective study.

Setting: University hospital in the Netherlands.

Patients: 19 patients (mean age ±SD, 66 ±14 years) with a large, compressive multinodular goiter who had a high operative risk or refused to have thyroid surgery.

Intervention: A single intravenous dose of Iodine-131 at 2.6 ±1.0 GBq (70 ±28 mCi) (3.7 MBq or 100 microcuries/g of thyroid tissue), followed by daily administration of L-thyroxine in doses that did not suppress thyroid-stimulating hormone.

Measurements: Clinical evaluation and measurements of thyroid volume, maximal tracheal deviation, and the smallest cross-sectional area of the tracheal lumen with magnetic resonance imaging before and 1 year after Iodine-131 treatment.

Results: No exacerbation of compressive symptoms after Iodine-131 therapy was observed. Thyroid volume was 269 ±153 mL before treatment and 154 ±73 mL 1 year after treatment (P < 0.001). Thyroid volume was reduced 40% ±15% (range, 19% to 68%). Maximal tracheal deviation (1.9 ±0.8 cm before and 1.5 ±0.7 cm 1 year after therapy) had decreased by 20% ±20% (range, –4% to 73%; P < 0.001), and the smallest cross-sectional area of the tracheal lumen (0.78 ±0.38 cm² before and 1.04 ±0.48 cm² 1 year after therapy) had increased by 36% ±38% (range, –3% to 125%; P < 0.001). Clinical signs and symptoms improved in 8 of 12 patients with dyspnea and inspiratory stridor and in both patients with compression of the superior vena cava.

Conclusions: Therapy with Iodine-131 is an effective alternative to surgery for elderly patients with a large, compressive multinodular goiter.

Author and Article Information

From the University Hospital Nijmegen, Nijmegen, the Netherlands.\\\\Requests for Reprints: Dyde A.K.C. Huysmans, MD, Department of Nuclear Medicine, De Weezenlanden Hospital, P.O. Box 10500, 8000 GM Zwolle, the Netherlands.
Acknowledgments: The authors thank the technicians of the departments of Nuclear Medicine, Radiology, and Pulmonary Medicine for their assistance; the nursing staff of unit E30 for their care of the patients; and Professor H. Folgering and Dr. J. Festen for their advice.

This article has been cited by other articles:

				S. J. Bonnema, V. E. Nielsen, H. Boel-Jorgensen, P. Grupe, P. B. Andersen, L. Bastholt, and L. Hegedus Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy of Large Nodular Goiters Facilitates Tracheal Decompression and Improves Inspiration J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3981 - 3984. [Abstract] [Full Text] [PDF]

				S. J. Bonnema, V. E. Nielsen, H. Boel-Jorgensen, P. Grupe, P. B. Andersen, L. Bastholt, and L. Hegedus Improvement of Goiter Volume Reduction after 0.3 mg Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with a Very Large Goiter: A Double-Blinded, Randomized Trial J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3424 - 3428. [Abstract] [Full Text] [PDF]

				C. C. Albino, C. O. Mesa Jr., M. Olandoski, C. E. Ueda, L. C. Woellner, C. A. Goedert, A. M. Souza, and H. Graf Recombinant Human Thyrotropin as Adjuvant in the Treatment of Multinodular Goiters with Radioiodine J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2775 - 2780. [Abstract] [Full Text] [PDF]

				W.-A. Nieuwlaat, A. R. Hermus, H. A. Ross, W. C. Buijs, M. A. Edelbroek, J. W. Bus, F. H. Corstens, and D. A. Huysmans Dosimetry of Radioiodine Therapy in Patients with Nodular Goiter After Pretreatment with a Single, Low Dose of Recombinant Human Thyroid-Stimulating Hormone J. Nucl. Med., April 1, 2004; 45(4): 626 - 633. [Abstract] [Full Text] [PDF]

				W.-A. Nieuwlaat, D. A. Huysmans, H. C. van den Bosch, C. G. (F. Sweep, H. A. Ross, F. H. Corstens, and A. R. Hermus Pretreatment with a Single, Low Dose of Recombinant Human Thyrotropin Allows Dose Reduction of Radioiodine Therapy in Patients with Nodular Goiter J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3121 - 3129. [Abstract] [Full Text] [PDF]

				L. Hegedus, S. J. Bonnema, and F. N. Bennedbaek Management of Simple Nodular Goiter: Current Status and Future Perspectives Endocr. Rev., February 1, 2003; 24(1): 102 - 132. [Abstract] [Full Text] [PDF]

				S. J. Bonnema, P. B. Andersen, D. U. Knudsen, and L. Hegedus MR Imaging of Large Multinodular Goiters: Observer Agreement on Volume Versus Observer Disagreement on Dimensions of the Involved Trachea Am. J. Roentgenol., July 1, 2002; 179(1): 259 - 266. [Abstract] [Full Text] [PDF]

				W.-A. Nieuwlaat, A. R. Hermus, F. Sivro-Prndelj, F. H. Corstens, and D. A. Huysmans Pretreatment with Recombinant Human TSH Changes the Regional Distribution of Radioiodine on Thyroid Scintigrams of Nodular Goiters J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5330 - 5336. [Abstract] [Full Text] [PDF]

				M. H. Samuels Editorial: Evaluation and Treatment of Sporadic Nontoxic Goiter--Some Answers and More Questions J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 994 - 997. [Full Text]

				M. F. T. Wesche, M. M. C. Tiel-v Buul, P. Lips, N. J. Smits, and W. M. Wiersinga A Randomized Trial Comparing Levothyroxine with Radioactive Iodine in the Treatment of Sporadic Nontoxic Goiter J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 998 - 1005. [Abstract] [Full Text]

				D. A. Huysmans, W.-A. Nieuwlaat, R. J. Erdtsieck, A. P. Schellekens, J. W. Bus, B. Bravenboer, and A. R. Hermus Administration of a Single Low Dose of Recombinant Human Thyrotropin Significantly Enhances Thyroid Radioiodide Uptake in Nontoxic Nodular Goiter J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3592 - 3596. [Abstract] [Full Text]

				S. J. Bonnema, H. Bertelsen, J. Mortensen, P. B. Andersen, D. U. Knudsen, L. Bastholt, and L. Hegedus The Feasibility of High Dose Iodine 131 Treatment as an Alternative to Surgery in Patients with a Very Large Goiter: Effect on Thyroid Function and Size and Pulmonary Function J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3636 - 3641. [Abstract] [Full Text] [PDF]

				B. Nygaard, L. Hegedus, P. Ulriksen, K. G. Nielsen, and J. M. Hansen Radioiodine Therapy for Multinodular Toxic Goiter Arch Intern Med, June 28, 1999; 159(12): 1364 - 1368. [Abstract] [Full Text] [PDF]

				A. R. Hermus and D. A. Huysmans Treatment of Benign Nodular Thyroid Disease N. Engl. J. Med., May 14, 1998; 338(20): 1438 - 1447. [Full Text] [PDF]

				B. Nygaard, J. H. Knudsen, L. Hegedus, A. V. C. Scient, and J. E. Molholm Hansen Thyrotropin Receptor Antibodies and Graves' Disease, a Side-Effect of 131I Treatment in Patients with Nontoxic Goiter J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2926 - 2930. [Abstract] [Full Text] [PDF]

				RADIOIODINE THERAPY FOR LARGE GOITERS Journal Watch (General), November 29, 1994; 1994(1129): 3 - 3. [Full Text]